Clinical course of infections with parvovirus B19 in children and adolescents

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00036034

Enrollment

250

Registered

2025-02-10

Start date

2024-08-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection with parvovirus B19 B08.3

Interventions

Group 1: Children and adolescents with evidence of infection with parvovirus B19 (09/2023-2025)

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Children and adolescents aged > 28 days to 18 years with virologically confirmed acute infection with parvovirus B19 through Detection of anti-PB19-IgM and/or positive DNA detection in the PCR

Exclusion criteria

Exclusion criteria: Age > 18 years Neonates with Z.n. intrauterine infection Pregnancy present at the time of infection detection

Design outcomes

Primary

Measure	Time frame
Frequency of specific complications, possibly in connection with the presence of underlying diseases, based on the available treatment data. Survey once retrospectively using a questionnaire.	—

Secondary

Measure	Time frame
Information on therapeutic interventions	—

Countries

Austria, Germany

Contacts

Public ContactMatthias Bleeke

Universitätsklinikum Hamburg-Eppendorf

m.bleeke@uke.de+4940741053796

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026